

Get to know us
At Genmab, we’re committed to building extra[not]ordinary® futures, together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases.
We are harnessing the power of precision medicine with the goal of delivering the right treatment to the right patient at the right time– and advance the future cancer treatment. Learn how we are leveraging novel approaches to make an impact on patient’s lives through innovative antibody medicines.
Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.
Passion
For Innovation
Determined
Being the Best at What We Do
Integrity
We Do the Right Thing
Work as One team
& Respect Each Other
Apply now to our upcoming events!

Top Women Tech
- 23/04/2027
- Brussels

Top Women Tech
- 20/11/2026
- Berlin

Top Women Tech
- 17/04/2026
- Paris

Top Women Tech
- 26/04/2025
- Brussels, Belgium

Top Women Tech
- 21/11/2025
- Berlin




